VIROS - Vienna Institute for Research in Ocular Surgers - Departement of Opthalmology - Hanusch Hospital
Vienna, 1140, Austria
NCT Number: NCT03465865
ILM-flap (internal limiting Membrane-flap) transposition is a new surgical option in repair of macular holes, therefore one year outcomes are needed to better evaluate that method.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vienna, 1140, Austria
Patients that have been scheduled for vitrectomy with ILM-flap transposition, a new surgical option in repair of macular holes, are invited to a follow-up one year after surgery, including optical coherence tomography and visual acuity testing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
optical coherence tomography enables diagosis of macular structures and therefore provides information on macular hole closure.
Other names: visual acuity test
Time frame: 5 minutes
macular hole closure is assessed with optical coherence tomography
Time frame: 5 minutes
visual acuity describes functional outcomes of the eye
Vienna Institute for Research in Ocular Surgery
Other
Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition for Surgical Repair of Macular Holes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02423161
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT05710458
Epiretinal Membrane, Eye Diseases
Hong Kong
View Trial DetailsNCT03020459
Eye Diseases, Macular Hole
Shanghai, China
View Trial DetailsNCT03452748
Epiretinal Membrane, Eye Diseases
Vienna, Austria
View Trial Details